WNT/β-catenin signaling in liver health and disease

被引:397
作者
Thompson, Michael D.
Monga, Satdarshan P. S.
机构
[1] Univ Pittsburgh, Inst Canc, MIRM Liver, Sch Med,Dept Pathol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Med Gastroenterol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1002/hep.21651
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Wnt/beta-catenin signaling is emerging as a forerunner for its critical roles in many facets of human biology. Its roles in embryogenesis, organogenesis, and maintaining tissue and organ homeostasis demonstrate its munificent character. Its roles in pathological conditions such as cancer and other human disorders such as inflammatory disorders and fibrosis reveal its villainous disposition. In liver, it also maintains its dual personality and is clearly of essence in several physiological events such as development, regeneration, and growth. Its aberrant activation is also evident in many different tumors of the liver, and recent studies are beginning to identify its role in additional hepatic pathological conditions. It is contributing to liver physiology and pathology by regulating various basic cellular events, including differentiation, proliferation, survival, oxidative stress, morphogenesis, and others. This review discusses the contribution of the Wnt/beta-catenin signaling pathway in these events and simultaneously provides an essential overview of the major developments in the field of Wnt/beta-catenin and liver pathobiology. In addition, areas that are currently deficient or understudied are identified and discussed along with the avenues of translational and clinical relevance.
引用
收藏
页码:1298 / 1305
页数:8
相关论文
共 57 条
  • [1] Transcriptional profiling implicates TGFβ/BMP and Notch signaling pathways in ductular differentiation of fetal murine hepatoblasts
    Ader, T
    Norel, R
    Levoci, L
    Rogler, LE
    [J]. MECHANISMS OF DEVELOPMENT, 2006, 123 (02) : 177 - 194
  • [2] Activation of Wnt/β-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice
    Apte, Udayan
    Zeng, Gang
    Muller, Peggy
    Tan, Xinping
    Micsenyi, Amanda
    Cieply, Benjamin
    Dai, Chunsun
    Liu, Youhua
    Kaestner, Klaus H.
    Monga, Satdarshan P. S.
    [J]. HEPATOLOGY, 2006, 44 (04) : 992 - 1002
  • [3] Expression of E-cadherin, α-catenin, β-catenin, and CD44 (Standard and variant isoforms) in human cholangiocarcinoma:: An immunohistochemical study
    Ashida, K
    Terada, T
    Kitamura, Y
    Kaibara, N
    [J]. HEPATOLOGY, 1998, 27 (04) : 974 - 982
  • [4] GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma
    Ban, KC
    Singh, H
    Krishnan, R
    Seow, HF
    [J]. CANCER LETTERS, 2003, 199 (02) : 201 - 208
  • [5] BEHARI J, 2006, J HEPATOL
  • [6] Apc tumor suppressor gene is the "zonation-keeper" of mouse liver
    Benhamouche, Samira
    Decaens, Thomas
    Godard, Cecile
    Chambrey, Regine
    Rickman, David S.
    Moinard, Christophe
    Vasseur-Cognet, Mireille
    Kuo, Calvin J.
    Kahn, Axel
    Perret, Christine
    Colnot, Sabine
    [J]. DEVELOPMENTAL CELL, 2006, 10 (06) : 759 - 770
  • [7] TCF: Lady justice casting the final verdict on the outcome of Wnt signalling
    Brantjes, H
    Barker, N
    van Es, J
    Clevers, H
    [J]. BIOLOGICAL CHEMISTRY, 2002, 383 (02) : 255 - 261
  • [8] Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions
    Brembeck, FH
    Schwarz-Romond, T
    Bakkers, J
    Wilhelm, S
    Hammerschmidt, M
    Birchmeier, W
    [J]. GENES & DEVELOPMENT, 2004, 18 (18) : 2225 - 2230
  • [9] New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
    Cadoret, A
    Ovejero, C
    Terris, B
    Souil, E
    Lévy, L
    Lamers, WH
    Kitajewski, J
    Kahn, A
    Perret, C
    [J]. ONCOGENE, 2002, 21 (54) : 8293 - 8301
  • [10] Cadoret A, 2001, CANCER RES, V61, P3245